Global Approaches to the Management of Relapsing Multiple Sclerosis
EP. 1: Diagnosis of Multiple Sclerosis: The McDonald Criteria
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 2: Differential Diagnosis of Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 3: MOG-IgG in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 4: Clinically Isolated Syndrome Versus Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 5: First-Line Therapies for Relapsing Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 6: The Use of Interferon in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 7: The Use of Glatiramer Acetate in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 8: Clinical Trials for Cladribine in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 9: Treating With Cladribine in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 10: Role of Siponimod in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 11: Ocrelizumab for the Treatment of Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 12: Role of Ocrelizumab in Europe for Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 13: Role of Diroximel Fumarate in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 14: Role of Ozanimod in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 15: Switching Therapies in Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 16: Decision-Making Process for Treating Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
EP. 17: The Future of Treating Multiple Sclerosis
BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD 
